Pharmaceutical preparations

Connect

Letters 3 Jan 2005

Subsidised access to TNF-α inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?

Erica L Mann

Med J Aust 2005; 182 (1): 47-48

Correction 3 Jan 2005

Correction: Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Haemostasis and Thrombosis

Ross I Baker, Paul B Coughlin, Hatem H Salem, Alex S Gallus, Paul L Harper and Erica M Wood

Med J Aust 2005; 182 (1): 48

Letters 3 Jan 2005

Tramadol and new-onset seizures

Angelo Labate, Mark R Newton, Graeme M Vernon and Samuel F Berkovic

Med J Aust 2005; 182 (1): 42-43

Research 15 Nov 2004

Effectiveness and side effects of thiazolidinediones for type 2 diabetes: real-life experience from a tertiary hospital

Zanariah Hussein, John M Wentworth, Alison J Nankervis, Joseph Proietto and Peter G Colman

Med J Aust 2004; 181 (10): 536-539 Free

For debate 15 Nov 2004

The dearth of new antibiotic development: why we should be worried and what we can do about it

Patrick G P Charles and M Lindsay Grayson

Med J Aust 2004; 181 (10): 549-553 Free

Letters 15 Nov 2004

Critical shortage of injectable thiamine in Australia

Simon Spedding and Matt D Gaughwin

Med J Aust 2004; 181 (10): 577-578

Letters 15 Nov 2004

Drugs, sport and the Olympics 2000-2004

Anthony P Millar

Med J Aust 2004; 181 (10): 584

Position statement 1 Nov 2004

Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis

Ross I Baker, Paul B Coughlin, Hatem H Salem, Alex S Gallus, Paul L Harper and Erica M Wood

Med J Aust 2004; 181 (9): 492-497 Free

Obituaries 1 Nov 2004

George Michael Eckert PhC, MB BS(Hons), MSc, PhD, MD

Allan J McLean, Lisa L Demos and Constantine G Berbatis

Med J Aust 2004; 181 (9): 503 Free

Letters 18 Oct 2004

Subsidised access to TNFα inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?

Christine Y Lu, Kenneth M Williams, Lyn March, James V Bertouch and Richard O Day

Med J Aust 2004; 181 (8): 457-458

Letters 18 Oct 2004

Subsidised access to TNFα inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?

Lloyd N Sansom

Med J Aust 2004; 181 (8): 457-458

Letters 18 Oct 2004

Preventing intrathecal administration of vincristine

Peter J Gilbar and Christine V Carrington

Med J Aust 2004; 181 (8): 464

Editorials 18 Oct 2004

Testosterone prescribing in Australia

Bronwyn GA Stuckey

Med J Aust 2004; 181 (8): 412-413

Research 18 Oct 2004

Trends and regional differences in testosterone prescribing in Australia, 1991–2001

David J Handelsman

Med J Aust 2004; 181 (8): 419-422 Free

New Drugs, Old Drugs 18 Oct 2004

The direct thrombin inhibitor melagatran/ximelagatran

Timothy A Brighton

Med J Aust 2004; 181 (8): 432-437 Free

Complementary and alternative medicine 20 Sep 2004

Cost-effectiveness findings not based on available evidence

Chris G Fenn

Med J Aust 2004; 181 (6): 339-339

Complementary and alternative medicine 20 Sep 2004

Making all data publicly available would be welcome

Leonie Segal, Richard H Osborne and Susan E Day

Med J Aust 2004; 181 (6): 339-340

Complementary and alternative medicine 20 Sep 2004

TTU is valuable for comparing disparate management options

Leonie Segal, Richard H Osborne and Susan E Day

Med J Aust 2004; 181 (6): 338-339

For debate 6 Sep 2004

Will the Australia–United States Free Trade Agreement undermine the Pharmaceutical Benefits Scheme?

Ken J Harvey, Thomas A Faunce, Buddhima Lokuge and Peter Drahos

Med J Aust 2004; 181 (5): 256-259

Clinical update 16 Aug 2004

Major advances in bipolar disorder

Philip B Mitchell, Gin S Malhi and Jillian R Ball

Med J Aust 2004; 181 (4): 207-210 Free

Complementary and alternative medicine 16 Aug 2004

The other side of the coin: safety of complementary and alternative medicine

Stephen P Myers and Phillip A Cheras

Med J Aust 2004; 181 (4): 222-225 Free

Letters 16 Aug 2004

Drugs, sport and the Olympics 2000–2004

Michael C Kennedy

Med J Aust 2004; 181 (4): 227

Letter 19 Jul 2004

Ciprofloxacin in the treatment of chronic suppurative otitis media

James D Kidd

Med J Aust 2004; 181 (2): 84

Complementary and alternative medicine 21 Jun 2004

Good medicine and bad medicine: science to promote the convergence of “alternative” and orthodox medicine

John M Dwyer

Med J Aust 2004; 180 (12): 647-648 Free

Editorials 7 Jun 2004

The beginning of the end of warfarin?

John W Eikelboom and Graeme J Hankey

Med J Aust 2004; 180 (11): 549-551

Pagination